focus -WSS

focus

author：Wikipedia 2025-10-01 00:58:34 - browse：553

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： WuXi Biologics beefs up its lobbying operation

focus

WSS

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Obesity drug from Roche shows promise in early study

Lilly’s weekly insulin works as well as daily products, new studies show

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

STAT reporters are Pulitzer Prize finalists for investigative reporting

hotspot

focus

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

Grail's uphill battle for Medicare to cover its cancer screening test

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Inflation cooled significantly in June, bringing price hikes close to normal levels

As demand for Covid shots wanes, Moderna seeks its next success

Watch the official trailer for 'Ahsoka' series

Drug repurposing or repositioning? The language matters

Grail's uphill battle for Medicare to cover its cancer screening test

Hepatitis C has a cure — but many Americans still lack access to it

Cherokee Nation medical school graduates its first class

focus

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Grail's uphill battle for Medicare to cover its cancer screening test

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Galapagos to make CAR

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Lilly’s weekly insulin works as well as daily products, new studies show

explore

Wikipedia

focus

entertainment